Chemometrically assisted optimization and validation of the HPLC method for the analysis of alectinib and its related impurity with measurement uncertainty evaluation and whiteness, blueness, and greenness profile assessments

Alectinib, the most common second-generation anaplastic lymphoma kinase inhibitor, is efficacious against various anaplastic lymphoma kinase mutations and is utilized in the treatment of non-small cell lung cancer. In this work, the determination of both alectinib and its impurity 5-trifluoroacetate at the same time was realized by developing a novel high performance liquid chromatography method. The stationary phase was an Ascentis<sup>®</sup> Express 90 Å C<sub>8</sub> (10 cm × 4.6 mm, 2.7 µm) HPLC column; the separation was obtained using a gradient system with a mobile phase consisting of acetonitrile and ammonium acetate buffer, and the responses were recorded from the PDA detector at a wavelength of 269 nm. The method's optimization was carried out using the Box-Behnken design, whereas the optimized conditions were selected according to the desirability function. Validation of the method was done with the International Council for Harmonization, ICH Q2(R2) Guidelines. The limit of detection values was 0.1 and 0.3 µg/mL, and the limit of quantification values were 0.3 and 0.5 µg/mL for alectinib and its impurity, respectively. The recovery study was realized in the Alecensa<sup>®</sup> capsule (150 mg alectinib/capsule), with high recoveries showing the perfect precision and accuracy of the method. A bottom-up approach was used to estimate the measurement uncertainty. This made it possible to find and measure the sources of uncertainty as well as the factors that affected the chromatographic responses. The resulting regression models were deemed adequate and were then used to define the operable design region using the Monte Carlo method. The eco-friendliness of the proposed methods was validated with the Complex Green Analytical Procedure Index, Analytical Greenness Metric and Blue Applicability Grade Index greenness evaluation tools. Also, the whiteness of the method was calculated with the newly developed White Analytical Chemistry tool. The method can be used to assay alectinib and its impurity agents in its formulation in quality control laboratories.

Authors

Institutions

Publication Details

Journal
BMC Chemistry
Published
2025-05-27
DOI
https://doi.org/10.1186/s13065-025-01509-y
Citations
1
Primary Topic
Analytical Methods in Pharmaceuticals
Type
article
Field-Weighted Citation Impact
0.75

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chemometrically assisted optimization and validation of the HPLC method for the analysis of alectinib and its related impurity with measurement uncertainty evaluation and whiteness, blueness, and greenness profile assessments

Nafiz Öncü Can, Saniye Özcan, Serkan Levent, Abeer Elriş et al.
1 citations
BMC Chemistry
Analytical Methods in Pharmaceuticals
0.75
article

Chemometrically assisted optimization and validation of the HPLC method for the analysis of alectinib and its related impurity with measurement uncertainty evaluation and whiteness, blueness, and greenness profile assessments

Nafiz Öncü Can, Saniye Özcan, Serkan Levent, Abeer Elriş, Hazal Avcı
article en
1 citations

Abstract

Alectinib, the most common second-generation anaplastic lymphoma kinase inhibitor, is efficacious against various anaplastic lymphoma kinase mutations and is utilized in the treatment of non-small cell lung cancer. In this work, the determination of both alectinib and its impurity 5-trifluoroacetate at the same time was realized by developing a novel high performance liquid chromatography method. The stationary phase was an Ascentis<sup>®</sup> Express 90 Å C<sub>8</sub> (10 cm × 4.6 mm, 2.7 µm) HPLC column; the separation was obtained using a gradient system with a mobile phase consisting of acetonitrile and ammonium acetate buffer, and the responses were recorded from the PDA detector at a wavelength of 269 nm. The method's optimization was carried out using the Box-Behnken design, whereas the optimized conditions were selected according to the desirability function. Validation of the method was done with the International Council for Harmonization, ICH Q2(R2) Guidelines. The limit of detection values was 0.1 and 0.3 µg/mL, and the limit of quantification values were 0.3 and 0.5 µg/mL for alectinib and its impurity, respectively. The recovery study was realized in the Alecensa<sup>®</sup> capsule (150 mg alectinib/capsule), with high recoveries showing the perfect precision and accuracy of the method. A bottom-up approach was used to estimate the measurement uncertainty. This made it possible to find and measure the sources of uncertainty as well as the factors that affected the chromatographic responses. The resulting regression models were deemed adequate and were then used to define the operable design region using the Monte Carlo method. The eco-friendliness of the proposed methods was validated with the Complex Green Analytical Procedure Index, Analytical Greenness Metric and Blue Applicability Grade Index greenness evaluation tools. Also, the whiteness of the method was calculated with the newly developed White Analytical Chemistry tool. The method can be used to assay alectinib and its impurity agents in its formulation in quality control laboratories.

BMC ChemistryVol. 19(1)
Anadolu University (TR)
Anadolu Üniversitesi
Climate action
Openalex Percentile: Top 32%
Analytical Methods in Pharmaceuticals
0.75
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.